Press Release HOME > NEWS > Press Release PharmCADD strategically collaborated with CNRS READ MORE The mayor, Hyung-Jun Park of Busan proposed vitalization of local human resource and knowledge leveraged by the collaboration among local governance, academy and industry READ MORE The capabilities of PharmCADD’s vaccine platform are being verified through approval of a phase I/IIa trial for mRNA COVID-19 vaccine READ MORE PharmCADD’s mRNA Vaccine design platform PharmVAC™: Eyegene Corona 19 vaccine candidate ‘EG-COVID’ mRNA sequence design READ MORE PharmCADD signed partnership for preparing KOSDAQ listing in next year with Korea Investment & Securities READ MORE PharmCADD signed a collaborative research contract for innovative new drug development with NeuroVenti for Autism. READ MORE PharmCADD moved into Cambridge Innovation Center (CIC) in Boston, USA. READ MORE PharmCADD introduced AI drug development progress to the ‘BIO KOREA 2021’ READ MORE Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021 READ MORE « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
The mayor, Hyung-Jun Park of Busan proposed vitalization of local human resource and knowledge leveraged by the collaboration among local governance, academy and industry READ MORE
The capabilities of PharmCADD’s vaccine platform are being verified through approval of a phase I/IIa trial for mRNA COVID-19 vaccine READ MORE
PharmCADD’s mRNA Vaccine design platform PharmVAC™: Eyegene Corona 19 vaccine candidate ‘EG-COVID’ mRNA sequence design READ MORE
PharmCADD signed partnership for preparing KOSDAQ listing in next year with Korea Investment & Securities READ MORE
PharmCADD signed a collaborative research contract for innovative new drug development with NeuroVenti for Autism. READ MORE